The proposed tumorigenic contribution of S100B has been associated with its ability to attenuate the tumor-suppressive activity of p53 by inhibiting p53 phosphorylation and regulating cell proliferation and differentiation through increasing mitogenic kinase Ndr (80) and Akt (81) activity (78). Here, AKT1 is linked to neoplasm.